Comparison
Ketamine vs MAOIs
MAOIs are powerful older antidepressants effective for atypical and treatment-resistant depression. They require strict dietary and drug interaction discipline. Ketamine offers comparable response without dietary restrictions.
Medically reviewed by: Pending medical review(draft)Last updated: June 4, 2026Evidence: Educational synthesis - not medical advice
Ketamine
MAOIs
Mechanism
NMDA antagonism with glutamatergic and neuroplastic downstream effects.
Inhibition of monoamine oxidase, raising serotonin, norepinephrine, and dopamine.
Evidence
Strong rapid-onset evidence in TRD.
Well-established for atypical depression and TRD; less commonly prescribed today.
Onset
Hours to days.
Two to six weeks.
Duration
Requires maintenance dosing or integration.
Ongoing while taken as prescribed.
Side effects
Transient dissociation, blood pressure, nausea.
Hypertensive crisis with tyramine-rich foods, insomnia, orthostatic hypotension, weight gain.
Access
Specialty clinics.
Psychiatry-prescribed; pharmacy-stocked but uncommon.
Best for
Patients seeking rapid relief without daily medication or dietary restriction.
Atypical depression; treatment-resistant patients willing to manage dietary restrictions.
Limits
Cost, access, requires repeat sessions.
Dietary and drug-interaction burden; slower onset.
Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.